1
|
Cejudo JC, Samaniego M, Almeria M, Castrillo S, Medina L, Gil D. Ikos Test: New Tool for the Assessment of Semantic Knowledge in Early Alzheimer Disease. J Alzheimers Dis 2022; 90:151-160. [DOI: 10.3233/jad-220516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background: Semantic memory (SM) constitutes a cognitive system that is seriously affected by Alzheimer’s disease (AD). There are several tests for assessing SM, but a tool is needed to assess AD in the early stages of the illness. Objective: The study aimed to create, validate, and normalize a new test to assess SM, called the Ikos test, for AD and early AD in clinical practice. Methods: 62 healthy adults as a control group (CG), 62 AD, and 60 amnestic mild cognitive impairment (aMCI) subdivided into a group that progresses to AD, and another group that does not progress to AD were selected. The internal consistency (IC), the construct validity (CV), and reliability between raters and the test-retest were analyzed. We used the Bayesian approach to establish the accuracy of the diagnosis of the Ikos test in AD and early AD. Results: IC showed a Kuder-Richardson index of r = 0.945. The CV between the Ikos test and Pyramids and Palm Trees; Intraclass Correlation Coefficient (ICC) index was 0.897. The Kappa index was between 0.865 and 0.912, and the ICC index was 0.873 for the test-retest reliability. The Area Under the Curve was 0.981, sensitivity (SE) was 0.95, and specificity (SP) was 0.96 in AD/CG. In contrast, in the MCI-AD/CG group, SE = 0.77 and SP = 0.80. Conclusion: The Ikos test accomplishes the criteria of validity and reliability with high correlation indexes. Therefore, it can be considered a valid, reliable, and easily applicable tool for SM assessment in diagnosing AD and the early stages of clinical disease.
Collapse
Affiliation(s)
- Juan Carlos Cejudo
- Cognitive Impairment and Dementia Unit, Hospital Sagrat Cor. Hermanas Hospitalarias, Martorell, (Barcelona), Spain
| | - Melissa Samaniego
- Cognitive Impairment and Dementia Unit, Hospital Sagrat Cor. Hermanas Hospitalarias, Martorell, (Barcelona), Spain
| | - Marta Almeria
- Cognition and Behavior Unit, Department of Neurology, Hospital Universitari Mútua Terrassa, Terrassa(Barcelona), Spain
- Department of Medicine, Autonomous University of Barcelona, (Barcelona), Spain
| | - Susana Castrillo
- RGG Sant Roc (DGPS), Drets Socials Dep, Generalitat de Catalunya, Spain
| | - Lidia Medina
- Cognitive Impairment and Dementia Unit. Hospital Atenció Intermedia MutuamGüell, EAPS Mutuam Barcelona, Barcelona, Spain
| | - Domènec Gil
- Cognitive Impairment and Dementia Unit, Hospital Sagrat Cor. Hermanas Hospitalarias, Martorell, (Barcelona), Spain
| |
Collapse
|
2
|
Sherman JC, Henderson CR, Flynn S, Gair JW, Lust B. Language Decline Characterizes Amnestic Mild Cognitive Impairment Independent of Cognitive Decline. JOURNAL OF SPEECH, LANGUAGE, AND HEARING RESEARCH : JSLHR 2021; 64:4287-4307. [PMID: 34699277 DOI: 10.1044/2021_jslhr-20-00503] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Purpose This research investigated the nature of cognitive decline in prodromal Alzheimer's disease (AD), particularly in mild cognitive impairment, amnestic type (aMCI). We assessed language in aMCI as compared with healthy aging (HA) and healthy young (HY) with new psycholinguistic assessment of complex sentences, and we tested the degree to which deficits on this language measure relate to performance in other general cognitive domains such as memory. Method Sixty-one individuals with aMCI were compared with 24 HA and 10 HY adults on a psycholinguistic measure of complex sentence production (relative clauses). In addition, HA, HY, and a subset of the aMCI participants (n = 22) were also tested on a multidomain cognitive screen, the Addenbrooke's Cognitive Examination-Revised (ACE-R), and on a verbal working memory Brown-Peterson (BP) test. General and generalized linear mixed models were used to test psycholinguistic results and to test whether ACE-R and BP performance predicted performance on the psycholinguistic test similarly in the aMCI and HA groups. Results On the psycholinguistic measure, sentence imitation was significantly deficited in aMCI in comparison with that in HA and HY. Experimental factorial designs revealed that individuals with aMCI had particular difficulty repeating sentences that especially challenged syntax-semantics integration. As expected, the aMCI group also performed significantly below the HY and HA groups on the ACE-R. Neither the ACE-R Memory subtest nor the BP total scores predicted performance on the psycholinguistic task for either the aMCI or the HA group. However, the ACE-R total score significantly predicted psycholinguistic task performance, with increased ACE-R performance predicting increased psycholinguistic task performance only for the HA group, not for the aMCI group. Conclusions Results suggest a selective deterioration in language in aMCI, specifically a weakening of syntax-semantics integration in complex sentence processing, and a general independence of this language deficit and memory decline. Results cohere with previous assessments of the nature of difficulty in complex sentence formation in aMCI. We argue that clinical screening for prodromal AD can be strengthened by supplementary testing of language, as well as memory, and extended evaluation of strength of their relation.
Collapse
Affiliation(s)
| | - Charles R Henderson
- Department of Psychology and Cognitive Science Cornell University, Ithaca, NY
| | - Suzanne Flynn
- Department of Linguistics and Philosophy, Massachusetts Institute of Technology, Cambridge
| | | | - Barbara Lust
- Department of Psychology and Cognitive Science Cornell University, Ithaca, NY
| |
Collapse
|
3
|
Jarry C, Osiurak F, Baumard J, Lesourd M, Coiffard C, Lucas C, Merck C, Etcharry-Bouyx F, Chauviré V, Belliard S, Moreaud O, Croisile B, Le Gall D. Daily life activities in patients with Alzheimer's disease or semantic dementia: Multitasking assessment. Neuropsychologia 2020; 150:107714. [PMID: 33285188 DOI: 10.1016/j.neuropsychologia.2020.107714] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2019] [Revised: 11/05/2020] [Accepted: 12/01/2020] [Indexed: 10/22/2022]
Abstract
The aim of the present study was to compare patients with mild to moderate Alzheimer's disease (AD) or semantic dementia (SD) on their cognitive processes and the severity of their daily life activity impairments. Three types of tasks were administered to patients (SD = 15; AD = 31) and 30 healthy controls (HC): 1) informant-based scales and questionnaires, 2) a neuropsychological assessment exploring executive functions, episodic and semantic memory, and 3) a new original test featuring multi-step naturalistic actions and multitasking: the Sequential Daily Life Multitasking (SDLM). We predicted that patients with AD would mainly exhibit task perplexity, associated with episodic and executive deficits on the SDLM, while the behavior of patients with SD would mostly be characterized by object perplexity, associated with semantic memory deficits. Results showed that patients with AD or SD were impaired across all neuropsychological tests, particularly episodic memory in AD and semantic memory in SD. General performance on the SDLM also appeared dramatically impaired in both patient groups, and correlated with results of questionnaires about instrumental activities and memory impairments. However, specific qualitative measurements on the SDLM did not allow us to pinpoint different patterns of errors and behavior in patients with AD versus SD. We suggest that the inability of patients in both groups to perform the SDLM may derive from a constellation of disorders or else from more subtle impairment of cognitive and conative processes that requires further exploration.
Collapse
Affiliation(s)
- Christophe Jarry
- Laboratoire de Psychologie des Pays de La Loire, LPPL EA 4638, SFR Confluences, UNIV Angers, Nantes Université, Maison de La Recherche Germaine Tillion, 5 Bis Boulevard Lavoisier, 49045 Angers, Cedex 01, France.
| | - François Osiurak
- Laboratoire d'Etude des Mécanismes Cognitifs (EA 3082), Université de Lyon, France; Institut Universitaire de France, Paris, France
| | | | - Mathieu Lesourd
- Laboratoire de Psychologie (EA3188), Université Bourgogne Franche Comté, France
| | - Clémence Coiffard
- Laboratoire de Psychologie des Pays de La Loire, LPPL EA 4638, SFR Confluences, UNIV Angers, Nantes Université, Maison de La Recherche Germaine Tillion, 5 Bis Boulevard Lavoisier, 49045 Angers, Cedex 01, France
| | - Charlène Lucas
- Laboratoire de Psychologie des Pays de La Loire, LPPL EA 4638, SFR Confluences, UNIV Angers, Nantes Université, Maison de La Recherche Germaine Tillion, 5 Bis Boulevard Lavoisier, 49045 Angers, Cedex 01, France
| | - Catherine Merck
- Service de Neurologie, Centre Hospitalier Universitaire Pontchaillou, CMRR, Rennes, France
| | - Frédérique Etcharry-Bouyx
- Laboratoire de Psychologie des Pays de La Loire, LPPL EA 4638, SFR Confluences, UNIV Angers, Nantes Université, Maison de La Recherche Germaine Tillion, 5 Bis Boulevard Lavoisier, 49045 Angers, Cedex 01, France; Unité de Neuropsychologie, Département de Neurologie, Centre Hospitalier Universitaire d'Angers, France
| | - Valérie Chauviré
- Unité de Neuropsychologie, Département de Neurologie, Centre Hospitalier Universitaire d'Angers, France
| | - Serge Belliard
- Service de Neurologie, Centre Hospitalier Universitaire Pontchaillou, CMRR, Rennes, France; Laboratoire de Neuropsychologie, Unité INSERM U 1077, Caen, France
| | - Olivier Moreaud
- CMRR Grenoble Arc Alpin, Pôle de Psychiatrie et Neurologie, Centre Hospitalier Universitaire de Grenoble, France; Laboratoire de Psychologie et Neurocognition CNRS UMR 5105, Grenoble, France
| | - Bernard Croisile
- Service de Neuropsychologie, Hôpital Neurologique Pierre Wertheimer, Bron, France
| | - Didier Le Gall
- Laboratoire de Psychologie des Pays de La Loire, LPPL EA 4638, SFR Confluences, UNIV Angers, Nantes Université, Maison de La Recherche Germaine Tillion, 5 Bis Boulevard Lavoisier, 49045 Angers, Cedex 01, France; Unité de Neuropsychologie, Département de Neurologie, Centre Hospitalier Universitaire d'Angers, France
| |
Collapse
|
4
|
Vonk JMJ, Twait EL, Scholten RJPM, Geerlings MI. Cross-sectional associations of amyloid burden with semantic cognition in older adults without dementia: A systematic review and meta-analysis. Mech Ageing Dev 2020; 192:111386. [PMID: 33091462 PMCID: PMC7952036 DOI: 10.1016/j.mad.2020.111386] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Revised: 09/13/2020] [Accepted: 10/14/2020] [Indexed: 12/31/2022]
Abstract
Previous research suggests the presence of subtle semantic decline in early stages of Alzheimer's disease. This study investigated associations between amyloid burden, a biomarker for Alzheimer's disease, and tasks of semantic impairment in older individuals without dementia. A systematic search in MEDLINE, PsycINFO, and Embase yielded 3691 peer-reviewed articles excluding duplicates. After screening, 41 studies with overall 7495 participants were included in the meta-analysis and quality assessment. The overall weighted effect size of the association between larger amyloid burden and larger semantic impairment was 0.10 (95% CI [-0.03; 0.22], p = 0.128) for picture naming, 0.19 (95% CI [0.11; 0.27], p < 0.001) for semantic fluency, 0.15 (95% CI [-0.15; 0.45], p = 0.326) for vocabulary, and 0.10 (95% CI [-0.14; 0.35], p = 0.405; 2 studies) for WAIS Information. Risk of bias was highest regarding comparability, as effect sizes were often not calculated on covariate-adjusted statistics. The relevance of the indicated amyloid-related decline in semantic fluency for research and clinical applications is likely negligible due to the effect's small magnitude. Future research should develop more sensitive metrics of semantic fluency to optimize its use for early detection of Alzheimer's disease-related cognitive impairment.
Collapse
Affiliation(s)
- Jet M J Vonk
- Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands; Department of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
| | - Emma L Twait
- Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
| | - Rob J P M Scholten
- Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
| | - Mirjam I Geerlings
- Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
| |
Collapse
|
5
|
Roncero C, Nikelski J, Probst S, Fernandez A, Thiel A, Chertkow H. The semantic storage loss score: An Algorithm for measuring an individual's level of semantic storage loss due to temporal lobe damage in neurodegenerative disease. PLoS One 2020; 15:e0235810. [PMID: 32810171 PMCID: PMC7433857 DOI: 10.1371/journal.pone.0235810] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2019] [Accepted: 06/24/2020] [Indexed: 11/18/2022] Open
Abstract
Anomia is common in Primary Progressive Aphasia (PPA), and there is considerable evidence that semantic problems (as opposed to impaired access to output word phonology) exist in many PPA individuals irrespective of their strict subtype, including a loss of representations from semantic memory, which is typical for people with the semantic variant of PPA. In this manuscript we present a straightforward novel clinical algorithm that quantifies this degree of semantic storage impairment. We sought to produce an algorithm by employing tasks that would measure key elements of semantic storage loss: a) whether an unrecalled name could be retrieved with cues; b) if performance for items was consistent across tasks; and c) the degree to which a participant’s performance was related to general severity of cognitive impairment rather than semantic loss. More specifically, these tasks were given to 28 individuals with PPA (12 participants had a clinical diagnosis of atypical Alzheimer’s Disease with the logopenic variant of PPA; the remaining 16 participants received a clinical diagnosis of Frontotemporal dementia (11 were classified as the non-fluent variant of PPA and five were the semantic variant of PPA). Scores from these tasks produced a single omnibus semantic memory storage loss score (SSL score) for each person that ranged from 0.0 to 1.0, with scores closer to 0 more indicative of semantic storage loss. Indeed, supporting the hypothesis that our scores measure the degree of semantic storage loss, we found participants with the semantic variant of PPA had the lowest scores, and SSL scores could predict the degree of hypometabolism in the anterior temporal lobe; even when only people with the logopenic variant of PPA were examined. Thus, these scores show promise quantitating the degree of a person’s semantic representation loss.
Collapse
Affiliation(s)
- Carlos Roncero
- Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montréal, Québec, Canada
- Baycrest Health Sciences, Rotman Research Institute, Toronto, Ontario, Canada
- * E-mail: (CR); (HC)
| | - Jim Nikelski
- Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montréal, Québec, Canada
| | - Stephan Probst
- Nuclear Medicine, Jewish General Hospital, McGill University, Montréal, Québec, Canada
| | - Alita Fernandez
- Baycrest Health Sciences, Rotman Research Institute, Toronto, Ontario, Canada
| | - Alex Thiel
- Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montréal, Québec, Canada
| | - Howard Chertkow
- Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montréal, Québec, Canada
- Baycrest Health Sciences, Rotman Research Institute, Toronto, Ontario, Canada
- * E-mail: (CR); (HC)
| |
Collapse
|
6
|
Rahul DR, Joseph Ponniah R. Language impairment in primary progressive aphasia and other neurodegenerative diseases. J Genet 2019. [DOI: 10.1007/s12041-019-1139-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
7
|
Effects of morphological family on word recognition in normal aging, mild cognitive impairment, and Alzheimer's disease. Cortex 2019; 116:91-103. [DOI: 10.1016/j.cortex.2018.10.028] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2017] [Revised: 07/21/2018] [Accepted: 10/31/2018] [Indexed: 11/20/2022]
|
8
|
Do Alzheimer's Disease Patients Benefit From Prior-Knowledge in Associative Recognition Memory? J Int Neuropsychol Soc 2019; 25:443-452. [PMID: 30696494 DOI: 10.1017/s1355617718001212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
OBJECTIVES Although the influence of prior knowledge on associative memory in healthy aging has received great attention, it has never been studied in Alzheimer's disease (AD). This study aimed at assessing whether AD patients could benefit from prior knowledge in associative memory and whether such benefit would be related to the integrity of their semantic memory. METHODS Twenty-one AD patients and 21 healthy older adults took part in an associative memory task using semantically related and unrelated word pairs and were also submitted to an evaluation of their semantic memory. RESULTS While participants of both groups benefited from semantic relatedness in associative discrimination, related pairs recognition was significantly predicted by semantic memory integrity in healthy older adults only. CONCLUSIONS We suggest that patients benefitted from semantic knowledge to improve their performance in the associative memory task, but that such performance is not related to semantic knowledge integrity evaluation measures because the two tasks differ in the way semantic information is accessed: in an automatic manner for the associative memory task, with automatic processes thought to be relatively preserved in AD, and in a controlled manner for the semantic knowledge evaluation, with controlled processes thought to be impaired in AD. (JINS, 2019, 25, 443-452).
Collapse
|
9
|
Anderson AJ, Lin F. How pattern information analyses of semantic brain activity elicited in language comprehension could contribute to the early identification of Alzheimer's Disease. Neuroimage Clin 2019; 22:101788. [PMID: 30991624 PMCID: PMC6451171 DOI: 10.1016/j.nicl.2019.101788] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2018] [Revised: 01/28/2019] [Accepted: 03/22/2019] [Indexed: 12/19/2022]
Abstract
Alzheimer's disease (AD) is associated with a loss of semantic knowledge reflecting brain pathophysiology that begins years before dementia. Identifying early signs of pathophysiology induced dysfunction in the neural systems that access and process words' meaning could therefore help forecast dementia. This article reviews pioneering studies demonstrating that abnormal functional Magnetic Resonance Imaging (fMRI) response patterns elicited in semantic tasks reflect both AD-pathophysiology and the hereditary risk of AD, and also can help forecast cognitive decline. However, to bring current semantic task-based fMRI research up to date with new AD research guidelines the relationship with different types of AD-pathophysiology needs to be more thoroughly examined. We shall argue that new analytic techniques and experimental paradigms will be critical for this. Previous work has relied on specialized tests of specific components of semantic knowledge/processing (e.g. famous name recognition) to reveal coarse AD-related changes in activation across broad brain regions. Recent computational advances now enable more detailed tests of the semantic information that is represented within brain regions during more natural language comprehension. These new methods stand to more directly index how pathophysiology alters neural information processing, whilst using language comprehension as the basis for a more comprehensive examination of semantic brain function. We here connect the semantic pattern information analysis literature up with AD research to raise awareness to potential cross-disciplinary research opportunities.
Collapse
Affiliation(s)
- Andrew James Anderson
- Department of Neuroscience, University of Rochester Medical Center, United States of America.
| | - Feng Lin
- Department of Neuroscience, University of Rochester Medical Center, United States of America; School of Nursing, University of Rochester Medical Center, United States of America; Department of Psychiatry, University of Rochester Medical Center, United States of America; Department of Neurology, University of Rochester Medical Center, United States of America; Department of Brain and Cognitive Sciences, University of Rochester, United States of America.
| |
Collapse
|
10
|
Douka S, Zilidou VI, Lilou O, Tsolaki M. Greek Traditional Dances: A Way to Support Intellectual, Psychological, and Motor Functions in Senior Citizens at Risk of Neurodegeneration. Front Aging Neurosci 2019; 11:6. [PMID: 30740051 PMCID: PMC6356054 DOI: 10.3389/fnagi.2019.00006] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2018] [Accepted: 01/10/2019] [Indexed: 12/14/2022] Open
Abstract
One of the major problems that elderly people are facing is dementia. For scientist’s dementia is a medical, social and economic problem, as it has been characterized as the epidemic of the 21st century. Prevention and treatment in the initial stages of dementia are essential, and community awareness and specialization of health professionals are required, with the aim of early and valid diagnosis of the disease. Activities are recommended to the senior citizens to improve their physical and mental health. Dance has been suggested as an appropriate recreational activity for the elderly that brings functional adjustments to the various systems of the body, psychological benefits, and makes exercise to seem interesting and entertaining as it combines the performance of multiple animations with musical accompaniment. A Greek traditional dance program was performed where our sample consisted of 30 healthy elderly and 30 with Mild Cognitive Impairment – MCI. It lasted 24 weeks, two times a week for 60 min. Specific traditional dances from all over Greece were selected. The dances were of a moderate intensity at the beginning with a gradual increase in intensity, according to the age and physical abilities of the participants. The results showed a significant improvement in: attention (S4viac-Healthy: z = -3.085, p = 0.002; MCI: z = -3.695, p < 0.001, S4viti-Healthy: z = -2.800, p = 0.005; MCI: z = -3.538, p < 0.001), anxiety (Healthy: z = -2.042, p = 0.041; MCI: z = -2.168, p = 0.030), verbal fluency for MCI (Verflx: t = -2.396, df = 29, p = 0.023, Verfls: t = -3.619, df = 29, p = 0.001, Verfmo: t = -3.295, df = 29, p = 0.003) and in executive functions (FUCAS: z = –2.168, p = 0.030). Significant improvement also showed in physical condition (Arm curl– Healthy: z = –3.253, p = 0.001; MCI: z = -3.308, p = 0.001, Chair stand – Healthy: t = –3.232, df = 29, p = 0.003; MCI: t = -2.242, df = 29, p = 0.033, Back scratch– Healthy: z = -1.946, p = 0.052; MCI: z = -2.845, p = 0.004, 2 min step– Healthy: z = –2.325, p = 0.020; MCI: z = -2.625, p = 0.009, FootUpandGo– Healthy: z = -4.289, p < 0.001; MCI: z = -3.137, p = 0.002, Sit and Reach: z = -3.082, p = 0.002, Balance on One leg: z = -3.301, p = 0.001) and Quality of life (Healthy: z = -1.937, p = 0.053; MCI: z = -2.130, p = 0.033). This study proves that dancing not only improves the cognitive and physical condition of the elderly but also contributes to a better quality of life.
Collapse
Affiliation(s)
- Styliani Douka
- Laboratory of Sports, Tourism and Recreation Management, School of Physical Education and Sport Science, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Vasiliki I Zilidou
- Laboratory of Sports, Tourism and Recreation Management, School of Physical Education and Sport Science, Aristotle University of Thessaloniki, Thessaloniki, Greece.,Laboratory of Medical Physics, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Olympia Lilou
- Laboratory of Sports, Tourism and Recreation Management, School of Physical Education and Sport Science, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Magda Tsolaki
- Department of Neurology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece
| |
Collapse
|
11
|
Zannino GD, Perri R, Teghil A, Caltagirone C, Carlesimo GA. Associative Agreement as a Predictor of Naming Ability in Alzheimer's Disease: A Case for the Semantic Nature of Associative Links. Front Behav Neurosci 2018; 11:261. [PMID: 29375334 PMCID: PMC5767179 DOI: 10.3389/fnbeh.2017.00261] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2017] [Accepted: 12/20/2017] [Indexed: 11/13/2022] Open
Abstract
We aimed to address the long-standing issue of the nature of the relationships that link a cue word to words associated with it. In keeping with a recently proposed neuropsychological model of semantic memory (Zannino et al., 2015), we provide support for the hypothesis that associative links are semantic in nature and not lexical. In support of this hypothesis, we demonstrate a relationship in healthy subjects between the probability of producing word X in response to cue word Y in a free association task and the probability of using word X to describe the meaning of word Y. Furthermore, we provide evidence that associative measures are altered in people suffering from Alzheimer's disease (AD) and predict their level of performance in a picture-naming task. We provide a parsimonious account of the experimental data gathered form these different sources of evidence according to the hypothesis that the links between a cue word and its associates can be viewed as binding a concept (the cue) to pieces of information regarding its meaning (the associates).
Collapse
Affiliation(s)
- Gian Daniele Zannino
- Laboratory of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Roberta Perri
- Laboratory of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy
| | - Alice Teghil
- Laboratory of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.,Department of Psychology, University of Rome La Sapienza, Rome, Italy
| | - Carlo Caltagirone
- Laboratory of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.,Department of Neurology, University of Rome Tor Vergata, Rome, Italy
| | - Giovanni A Carlesimo
- Laboratory of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.,Department of Neurology, University of Rome Tor Vergata, Rome, Italy
| |
Collapse
|
12
|
Nilsson H, Berglund JS, Renvert S. Periodontitis, tooth loss and cognitive functions among older adults. Clin Oral Investig 2017; 22:2103-2109. [PMID: 29270902 DOI: 10.1007/s00784-017-2307-8] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2017] [Accepted: 12/11/2017] [Indexed: 12/25/2022]
Abstract
OBJECTIVE This study aims to evaluate the potential association between periodontitis, the number of teeth and cognitive functions in a cohort of older adults in Sweden. MATERIAL AND METHODS In total, 775 individuals from 60 to 99 years of age were selected for the study. A clinical and radiographic examination was performed. The number of teeth and prevalence of periodontal pockets and bone loss was calculated and categorised. Cognitive functions were assessed using the Mini-Mental State Examination (MMSE) and clock test. The education level was obtained from a questionnaire. Data were analysed using chi-square tests and multivariate logistic regression. RESULTS Age and gender were associated with the prevalence of bone loss. Age and education were associated with lower number of teeth. Gender was also associated with the presence of pockets. The multivariate logistic regression analysis demonstrated a statistically significant association between prevalence of bone loss, the number of teeth and the outcome on MMSE test. This association remained even after adjustment for age, education and gender. Tooth loss was also associated with lower outcome on clock test. Presence of periodontal pockets ≥ 5 mm was not associated with cognitive test outcome. CONCLUSIONS A history of periodontitis and tooth loss may be of importance for cognitive functions among older adults. CLINICAL RELEVANCE Diseases with and inflammatory profile may have an impact on cognitive decline.
Collapse
Affiliation(s)
- Helena Nilsson
- Maxillofacial Unit, Halland Hospital, 30185, Halmstad, Sweden.
| | - Johan Sanmartin Berglund
- Blekinge Institute of Technology, Karlskrona, Sweden
- Department of Clinical Sciences, Lund University, Lund, Sweden
| | - Stefan Renvert
- Blekinge Institute of Technology, Karlskrona, Sweden
- School of Health and Society, Kristianstad University, Kristianstad, Sweden
- School of Dental Science, Trinity College, Dublin, Ireland
| |
Collapse
|
13
|
Orlovsky I, Huijbers W, Hanseeuw BJ, Mormino EC, Hedden T, Buckley RF, LaPoint M, Rabin JS, Rentz DM, Johnson KA, Sperling RA, Papp KV. The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING 2017; 10:121-129. [PMID: 29780861 PMCID: PMC5956796 DOI: 10.1016/j.dadm.2017.11.003] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Introduction Alzheimer's disease (AD) patients exhibit temporally graded memory loss with remote memories remaining more intact than recent memories. It is unclear whether this temporal pattern is observable in clinically normal adults with amyloid pathology (i.e. preclinical AD). Methods Participants were asked to recall the names of famous figures most prominent recently (famous after 1990) and remotely (famous from 1960–1980) and were provided with a phonemic cue to ensure that memory failure was not purely due to verbal retrieval weaknesses. In addition, participants identified line drawings of objects. Clinically normal older adults (n = 125) were identified as amyloid β positive or negative (Aβ+/−) using Pittsburgh compound B positron emission tomography. The relationship between Aβ+/− and recall of remote and recent famous face-names and objects was examined using repeated measures analyses and general linear models controlling for demographics and media usage. Results When provided with a phonemic cue, Aβ+ participants recalled the names of fewer recent famous faces compared with Aβ− participants. However, recall of remote famous face-names and objects did not differ by Aβ group. Discussion Relative sparing of remotely learned information compared with recently learned information is (1) detectable in the preclinical stages of AD and (2) related to amyloid pathology. Both this temporal gradient and assessment of person-centered rather than object-centered semantic information may be particularly meaningful for tracking early memory changes in the AD trajectory.
Collapse
Affiliation(s)
- Irina Orlovsky
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Willem Huijbers
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Tilburg University, Department of Cognitive Science and Artificial Intelligence, Jheronimus Academy of Data Science, Tilburg, Netherlands
| | - Bernard J Hanseeuw
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Neurology Department, Cliniques Universitaires Saint-Luc, Institute of Neuroscience, Université Catholique de Louvain, Brussels, Belgium
| | - Elizabeth C Mormino
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, CA, USA
| | - Trey Hedden
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Rachel F Buckley
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Molly LaPoint
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Jennifer S Rabin
- Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Dorene M Rentz
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Keith A Johnson
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Reisa A Sperling
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Kathryn V Papp
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.,Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| |
Collapse
|
14
|
Venneri A, Mitolo M, De Marco M. Paradigm shift: semantic memory decline as a biomarker of preclinical Alzheimer's disease. Biomark Med 2016; 10:5-8. [DOI: 10.2217/bmm.15.53] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Affiliation(s)
- Annalena Venneri
- Department of Neuroscience, University of Sheffield, Beech Hill Road, Sheffield, South Yorkshire, S10 2RX, UK
- IRCCS, Fondazione Ospedale San Camillo, Venice, Italy
| | | | - Matteo De Marco
- Department of Neuroscience, University of Sheffield, Beech Hill Road, Sheffield, South Yorkshire, S10 2RX, UK
| |
Collapse
|
15
|
Abstract
Symbols and signs have been suggested to improve the orientation of patients suffering from Alzheimer disease (AD). However, there are hardly any studies that confirm whether AD patients benefit from signs or symbols and which symbol characteristics might improve or impede their symbol comprehension. To address these issues, 30 AD patients and 30 matched healthy controls performed a symbol processing task (SPT) with 4 different item categories. A repeated-measures analysis of variance was run to identify impact of different item categories on performance accuracy in both the experimental groups. Moreover, SPT scores were correlated with neuropsychological test scores in a broad range of other cognitive domains. Finally, diagnostic accuracy of the SPT was calculated by a receiver-operating characteristic curve analysis. Results revealed a global symbol processing dysfunction in AD that was associated with semantic memory and executive deficits. Moreover, AD patients showed a disproportional performance decline at SPT items with visual distraction. Finally, the SPT total score showed high sensitivity and specificity in differentiating between AD patients and healthy controls. The present findings suggest that specific symbol features impede symbol processing in AD and argue for a diagnostic benefit of the SPT in neuropsychological assessment.
Collapse
|
16
|
Daffner KR, Gale SA, Barrett AM, Boeve BF, Chatterjee A, Coslett HB, D'Esposito M, Finney GR, Gitelman DR, Hart JJ, Lerner AJ, Meador KJ, Pietras AC, Voeller KS, Kaufer DI. Improving clinical cognitive testing: report of the AAN Behavioral Neurology Section Workgroup. Neurology 2015; 85:910-8. [PMID: 26163433 DOI: 10.1212/wnl.0000000000001763] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2014] [Accepted: 05/07/2015] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To evaluate the evidence basis of single-domain cognitive tests frequently used by behavioral neurologists in an effort to improve the quality of clinical cognitive assessment. METHODS Behavioral Neurology Section members of the American Academy of Neurology were surveyed about how they conduct clinical cognitive testing, with a particular focus on the Neurobehavioral Status Exam (NBSE). In contrast to general screening cognitive tests, an NBSE consists of tests of individual cognitive domains (e.g., memory or language) that provide a more comprehensive diagnostic assessment. Workgroups for each of 5 cognitive domains (attention, executive function, memory, language, and spatial cognition) conducted evidence-based reviews of frequently used tests. Reviews focused on suitability for office-based clinical practice, including test administration time, accessibility of normative data, disease populations studied, and availability in the public domain. RESULTS Demographic and clinical practice data were obtained from 200 respondents who reported using a wide range of cognitive tests. Based on survey data and ancillary information, between 5 and 15 tests in each cognitive domain were reviewed. Within each domain, several tests are highlighted as being well-suited for an NBSE. CONCLUSIONS We identified frequently used single-domain cognitive tests that are suitable for an NBSE to help make informed choices about clinical cognitive assessment. Some frequently used tests have limited normative data or have not been well-studied in common neurologic disorders. Utilizing standardized cognitive tests, particularly those with normative data based on the individual's age and educational level, can enhance the rigor and utility of clinical cognitive assessment.
Collapse
Affiliation(s)
- Kirk R Daffner
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill.
| | - Seth A Gale
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - A M Barrett
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - Bradley F Boeve
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - Anjan Chatterjee
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - H Branch Coslett
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - Mark D'Esposito
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - Glen R Finney
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - Darren R Gitelman
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - John J Hart
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - Alan J Lerner
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - Kimford J Meador
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - Alison C Pietras
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - Kytja S Voeller
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| | - Daniel I Kaufer
- From the Center for Brain/Mind Medicine (K.R.D., S.A.G., A.C.P.), Division of Cognitive and Behavioral Neurology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Kessler Foundation Research Center (A.M.B.), West Orange, NJ; Department of Neurology (B.F.B.), Mayo Clinic, Rochester, MN; Department of Neurology and Center for Cognitive Neuroscience (A.C., H.B.C.), University of Pennsylvania, Philadelphia; Helen Wills Neuroscience Institute (M.D.), University of California, Berkeley; Department of Neurology (G.R.F.), University of Florida College of Medicine, Gainesville; Department of Neurology (D.R.G.), Northwestern University, Feinberg School of Medicine, Chicago, IL; Center for Brain Health (J.J.H.), School of Behavioral & Brain Sciences, University of Texas at Dallas; Department of Neurology (A.J.L.), University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH; Department of Neurology and Neurological Sciences (K.J.M.), Stanford Comprehensive Epilepsy Center, Stanford University School of Medicine, CA; Western Institute for Neurodevelopmental Studies and Interventions (K.S.V.), Boulder, CO; and Memory Disorders Program (D.I.K.), UNC Department of Neurology, University of North Carolina at Chapel Hill
| |
Collapse
|
17
|
Callahan BL, Joubert S, Tremblay MP, Macoir J, Belleville S, Rousseau F, Bouchard RW, Verret L, Hudon C. Semantic memory impairment for biological and man-made objects in individuals with amnestic mild cognitive impairment or late-life depression. J Geriatr Psychiatry Neurol 2015; 28:108-16. [PMID: 25344480 DOI: 10.1177/0891988714554708] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/10/2014] [Accepted: 06/10/2014] [Indexed: 11/17/2022]
Abstract
OBJECTIVE Amnestic mild cognitive impairment (aMCI) and late-life depression (LLD) both increase the risk of developing Alzheimer disease (AD). Very little is known about the similarities and differences between these syndromes. The present study addresses this issue by examining the nature of semantic memory impairment (more precisely, object-based knowledge) in patients at risk of developing AD. METHODS Participants were 17 elderly patients with aMCI, 18 patients with aMCI plus depressive symptoms (aMCI/D+), 15 patients with LLD, and 29 healthy controls. All participants were aged 55 years or older and were administered a semantic battery designed to assess semantic knowledge for 16 biological and 16 man-made items. RESULTS Overall performance of aMCI/D+ participants was significantly worse than the 3 other groups, and performance for questions assessing knowledge for biological items was poorer than for questions relating to man-made items. CONCLUSION This study is the first to show that aMCI/D+ is associated with object-based semantic memory impairment. These results support the view that semantic deficits in aMCI are associated with concomitant depressive symptoms. However, depressive symptoms alone do not account exclusively for semantic impairment, since patients with LLD showed no semantic memory deficit.
Collapse
Affiliation(s)
- Brandy L Callahan
- École de psychologie, Université Laval, Quebec, Canada Centre de recherche de l'Institut universitaire en santé mentale de Québec, Quebec, Canada
| | - Sven Joubert
- Département de psychologie, Université de Montréal, Montreal, Canada Centre de recherche de l'Institut universitaire de gériatrie de Montréal, Montreal, Canada
| | - Marie-Pier Tremblay
- École de psychologie, Université Laval, Quebec, Canada Centre de recherche de l'Institut universitaire en santé mentale de Québec, Quebec, Canada
| | - Joël Macoir
- Centre de recherche de l'Institut universitaire en santé mentale de Québec, Quebec, Canada Département de réadaptation, Université Laval, Quebec, Canada
| | - Sylvie Belleville
- Département de psychologie, Université de Montréal, Montreal, Canada Centre de recherche de l'Institut universitaire de gériatrie de Montréal, Montreal, Canada
| | | | - Rémi W Bouchard
- Clinique interdisciplinaire de la mémoire du CHU de Québec, Quebec, Canada
| | - Louis Verret
- Clinique interdisciplinaire de la mémoire du CHU de Québec, Quebec, Canada
| | - Carol Hudon
- École de psychologie, Université Laval, Quebec, Canada Centre de recherche de l'Institut universitaire en santé mentale de Québec, Quebec, Canada
| |
Collapse
|
18
|
Sava AA, Paquet C, Krolak-Salmon P, Dumurgier J, Hugon J, Chainay H. Emotional memory enhancement in respect of positive visual stimuli in Alzheimer's disease emerges after rich and deep encoding. Cortex 2015; 65:89-101. [DOI: 10.1016/j.cortex.2015.01.002] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2014] [Revised: 10/22/2014] [Accepted: 01/05/2015] [Indexed: 12/28/2022]
|
19
|
Toepper M, Boedeker S, Bauer E, Westphal S, Driessen M, Beblo T. Does Mount Vesuvius indicate an outbreak of Alzheimer's disease? J Am Geriatr Soc 2014; 62:1989-91. [PMID: 25333539 DOI: 10.1111/jgs.13042] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Max Toepper
- Research Department, Department of Geriatric Psychiatry, Clinic of Psychiatry and Psychotherapy Bethel, Evangelic Hospital Bielefeld, Bielefeld, Germany
| | | | | | | | | | | |
Collapse
|
20
|
Vallet GT, Hudon C, Simard M, Versace R. The disconnection syndrome in the Alzheimer’s disease: The cross-modal priming example. Cortex 2013; 49:2402-15. [DOI: 10.1016/j.cortex.2012.10.010] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2012] [Revised: 09/06/2012] [Accepted: 10/23/2012] [Indexed: 01/01/2023]
|
21
|
Harciarek M, Cosentino S. Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes. Int Rev Psychiatry 2013; 25:178-96. [PMID: 23611348 PMCID: PMC4481322 DOI: 10.3109/09540261.2013.763340] [Citation(s) in RCA: 50] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Frontotemporal dementia (FTD) represents a spectrum of non-Alzheimer's degenerative conditions associated with focal atrophy of the frontal and/or temporal lobes. Frontal and temporal regions of the brain have been shown to be strongly involved in executive function, social cognition and language processing and, thus, deficits in these domains are frequently seen in patients with FTD or may even be hallmarks of a specific FTD subtype (i.e. relatively selective and progressive language impairment in primary progressive aphasia). In this review we have attempted to delineate how language, executive function, and social cognition may contribute to the diagnosis of FTD syndromes, namely the behavioural variant FTD as well as the language variants of FTD including the three subtypes of primary progressive aphasia (PPA): non-fluent/agrammatic, semantic and logopenic. This review also addresses the extent to which deficits in these cognitive areas contribute to the differential diagnosis of FTD versus Alzheimer's disease (AD). Finally, early clinical determinants of pathology are briefly discussed and contemporary challenges to the diagnosis of FTD are presented.
Collapse
Affiliation(s)
- Michał Harciarek
- Division of Clinical Psychology and Neuropsychology, Institute of Psychology, University of Gdańsk, Poland.
| | | |
Collapse
|
22
|
Gildengers AG, Chisholm D, Butters MA, Anderson SJ, Begley A, Holm M, Rogers JC, Reynolds CF, Mulsant BH. Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression? Psychol Med 2013; 43:801-11. [PMID: 22846332 PMCID: PMC3593938 DOI: 10.1017/s0033291712001614] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
BACKGROUND While bipolar disorder (BD) is a leading cause of disability, and an important contributor to disability in BD is cognitive impairment, there is little systematic research on the longitudinal course of cognitive function and instrumental activities of daily living (IADLs) in late-life. In this report, we characterize the 2-year course of cognitive function and IADLs in older adults with BD. Method We recruited non-demented individuals 50 years and older with BD I or BD II (n = 47) from out-patient clinics or treatment studies at the University of Pittsburgh. Comparator subjects ('controls') were 22 individuals of comparable age and education with no psychiatric or neurologic history, but similar levels of cardiovascular disease. We assessed cognitive function and IADLs at baseline, 1- and 2-year time-points. The neuropsychological evaluation comprised 21 well-established and validated tests assessing multiple cognitive domains. We assessed IADLs using a criterion-referenced, performance-based instrument. We employed repeated-measures mixed-effects linear models to examine trajectory of cognitive function. We employed non-parametric tests for analysis of IADLs. RESULTS The BD group displayed worse cognitive function in all domains and worse IADL performance than the comparator group at baseline and over follow-up. Global cognitive function and IADLs were correlated at all time-points. The BD group did not exhibit accelerated cognitive decline over 2 years. CONCLUSIONS Over 2 years, cognitive impairment and associated functional disability of older adults with BD appear to be due to long-standing neuroprogressive processes compounded by normal cognitive aging rather than accelerated cognitive loss in old age.
Collapse
Affiliation(s)
- A. G. Gildengers
- University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, PA, USA
| | - D. Chisholm
- University of Pittsburgh School of Rehabilitation Sciences, Department of Occupational Therapy, Pittsburgh, PA, USA
| | - M. A. Butters
- University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, PA, USA
| | - S. J. Anderson
- University of Pittsburgh Graduate School of Public Health, Department of Biostatistics, Pittsburgh, PA, USA
| | - A. Begley
- University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, PA, USA
| | - M. Holm
- University of Pittsburgh School of Rehabilitation Sciences, Department of Occupational Therapy, Pittsburgh, PA, USA
| | - J. C. Rogers
- University of Pittsburgh School of Rehabilitation Sciences, Department of Occupational Therapy, Pittsburgh, PA, USA
| | - C. F. Reynolds
- University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, PA, USA
| | - B. H. Mulsant
- Centre for Addiction and Mental Health and the University of Toronto, Department of Psychiatry, Toronto, ON, Canada
| |
Collapse
|
23
|
Category-specific semantic memory: converging evidence from bold fMRI and Alzheimer's disease. Neuroimage 2012; 68:263-74. [PMID: 23220494 DOI: 10.1016/j.neuroimage.2012.11.057] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2011] [Revised: 09/30/2012] [Accepted: 11/26/2012] [Indexed: 01/18/2023] Open
Abstract
Patients with Alzheimer's disease have category-specific semantic memory difficulty for natural relative to manufactured objects. We assessed the basis for this deficit by asking healthy adults and patients to judge whether pairs of words share a feature (e.g. "banana:lemon-COLOR"). In an fMRI study, healthy adults showed gray matter (GM) activation of temporal-occipital cortex (TOC) where visual-perceptual features may be represented, and prefrontal cortex (PFC) which may contribute to feature selection. Tractography revealed dorsal and ventral stream white matter (WM) projections between PFC and TOC. Patients had greater difficulty with natural than manufactured objects. This was associated with greater overlap between diseased GM areas correlated with natural kinds in patients and fMRI activation in healthy adults for natural kinds. The dorsal WM projection between PFC and TOC in patients correlated only with judgments of natural kinds. Patients thus remained dependent on the same neural network as controls during judgments of natural kinds, despite disease in these areas. For manufactured objects, patients' judgments showed limited correlations with PFC and TOC GM areas activated by controls, and did not correlate with the PFC-TOC dorsal WM tract. Regions outside of the PFC-TOC network thus may help support patients' judgments of manufactured objects. We conclude that a large-scale neural network for semantic memory implicates both feature knowledge representations in modality-specific association cortex and heteromodal regions important for accessing this knowledge, and that patients' relative deficit for natural kinds is due in part to their dependence on this network despite disease in these areas.
Collapse
|
24
|
Age-dependent decline of motor neocortex but not hippocampal performance in heterozygous BDNF mice correlates with a decrease of cortical PSD-95 but an increase of hippocampal TrkB levels. Exp Neurol 2012; 237:335-45. [PMID: 22776425 DOI: 10.1016/j.expneurol.2012.06.033] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2012] [Revised: 06/25/2012] [Accepted: 06/28/2012] [Indexed: 12/12/2022]
Abstract
Brain-derived neurotrophic factor (BDNF) is a key player in learning and memory processes. However, little is known about brain area-specific functions of this neurotrophin. Here we investigated whether BDNF could differently affect motor neocortical and hippocampal-related cognitive and plastic morphologic changes in young (12-week-old) and middle-aged (30-week-old) BDNF heterozygous (BDNF⁺/⁻) and wild type (wt) mice. We found that at 30 weeks of age, BDNF⁺/⁻ mice showed impaired performance in accelerating rotarod and grasping tests while preserved spatial learning in a T-maze and recognition memory in an object recognition task compared with wt mice suggesting a specific neocortical dysfunction. Accordingly, a significant reduction of synaptic markers (PSD-95 and GluR1) and corresponding puncta was observed in motor neocortex but not in hippocampus of BDNF⁺/⁻ mice. Interestingly, 30-week-old BDNF⁺/⁻ mice displayed increased TrkB levels in the hippocampus but not in the motor neocortex, which suggests specific hippocampal compensatory mechanisms as a consequence of BDNF decrease. In conclusion, our data indicates that BDNF could differentially regulate the neuronal micro-structures and cognition in a region-specific and in an age-dependent manner.
Collapse
|
25
|
Domoto-Reilly K, Sapolsky D, Brickhouse M, Dickerson BC. Naming impairment in Alzheimer's disease is associated with left anterior temporal lobe atrophy. Neuroimage 2012; 63:348-55. [PMID: 22728617 DOI: 10.1016/j.neuroimage.2012.06.018] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2011] [Revised: 06/10/2012] [Accepted: 06/13/2012] [Indexed: 10/28/2022] Open
Abstract
There is considerable debate about the neuroanatomic localization of semantic memory, the knowledge of culturally shared elements such as objects, concepts, and people. Two recent meta-analyses of functional imaging studies (fMRI and PET) sought to identify cortical regions involved in semantic processing. Binder and colleagues (Binder et al., 2009) identified several regions of interest, widely distributed throughout the frontal, parietal, and temporal cortices. In contrast, Lambon Ralph and colleagues (2010) focused on the anterior temporal lobe, and found that when the potential for signal loss is accounted for (due, for example, to distortion artifact or field of view restriction), significant regional activation is detected. We set out to determine whether the anterior temporal lobe plays a significant role in picture naming, a task which relies on semantic memory. We examined a relatively large sample of patients with early Alzheimer's disease (N=145), a multifocal disease process typically characterized in the early stages by problems with episodic memory and executive function. Hypothesis-driven analyses based on regions of interest derived from the meta-analyses as well as exploratory analyses across the entire cerebral cortex demonstrated a highly specific correlation between cortical thinning of the left anterior temporal lobe and impaired naming performance. These findings lend further support to theories that include a prominent role for the anterior temporal lobe in tasks that rely on semantic memory.
Collapse
Affiliation(s)
- Kimiko Domoto-Reilly
- Frontotemporal Dementia Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129, USA.
| | | | | | | | | |
Collapse
|
26
|
Rohrer JD, Rossor MN, Warren JD. Alzheimer's pathology in primary progressive aphasia. Neurobiol Aging 2012; 33:744-52. [PMID: 20580129 PMCID: PMC3314936 DOI: 10.1016/j.neurobiolaging.2010.05.020] [Citation(s) in RCA: 92] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2009] [Revised: 03/13/2010] [Accepted: 05/17/2010] [Indexed: 10/26/2022]
Abstract
Primary progressive aphasia (PPA) is a neurodegenerative disorder with language impairment as the primary feature. Different subtypes have been described and the 3 best characterized are progressive nonfluent aphasia (PNFA), semantic dementia (SD) and logopenic/phonological aphasia (LPA). Of these subtypes, LPA is most commonly associated with Alzheimer's disease (AD) pathology. However, the features of PPA associated with AD have not been fully defined. Here we retrospectively identified 14 patients with PPA and either pathologically confirmed AD or cerebrospinal fluid (CSF) biomarkers consistent with AD. Analysis of neurological and neuropsychological features revealed that all patients had a syndrome of LPA with relatively nonfluent spontaneous speech, phonemic errors, and reduced digit span; most patients also had impaired verbal episodic memory. Analysis of the pattern of cortical thinning in these patients revealed left posterior superior temporal, inferior parietal, medial temporal, and posterior cingulate involvement and in patients with more severe disease, increasing involvement of left anterior temporal and frontal cortices and right hemisphere areas in the temporo-parietal junction, posterior cingulate, and medial temporal lobe. We propose that LPA may be a "unihemispheric" presentation of AD, and discuss this concept in relation to accumulating evidence concerning language dysfunction in AD.
Collapse
Affiliation(s)
| | | | - Jason D. Warren
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, Queen Square, London, United Kingdom
| |
Collapse
|
27
|
Hanaki R, Abe N, Fujii T, Ueno A, Nishio Y, Hiraoka K, Shimomura T, Iizuka O, Shinohara M, Hirayama K, Mori E. The effects of aging and Alzheimer's disease on associative recognition memory. Neurol Sci 2011; 32:1115-22. [PMID: 21904867 DOI: 10.1007/s10072-011-0748-4] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2010] [Accepted: 08/23/2011] [Indexed: 11/28/2022]
Abstract
We investigated the effects of aging and Alzheimer's disease (AD) on item and associative recognition memory. Three groups of participants (younger adults, elderly adults, and AD patients) studied photographs of common objects that were located on either the left or the right side of a black computer screen inside either a red or a blue square. In a subsequent old/new recognition memory test, the participants were presented with four kinds of stimuli: "intact" stimuli, which were presented as they were during the study phase; "location-altered" stimuli, which were presented in a different location; "color-altered" stimuli, which were presented with a different surrounding color; and "new" stimuli, which consisted of photographs that had not been presented during the study phase. Compared with younger adults, the older adults showed equivalent performance in simple item recognition but worse performance in discriminating location-altered and color-altered stimuli. Compared with older adults, the AD patients showed equivalent performance in discriminating color-altered stimuli but worse performance in simple item recognition and the discrimination of location-altered stimuli. We speculate that distinct structural and functional changes in specific brain regions that are caused by aging and AD are responsible for the different patterns of memory impairment.
Collapse
Affiliation(s)
- Risa Hanaki
- Department of Behavioral Neurology and Cognitive Neuroscience, Tohoku University Graduate School of Medicine, Sendai, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Razani J, Chan A, Nordin S, Murphy C. Semantic networks for odors and colors in Alzheimer's disease. Neuropsychology 2010; 24:291-9. [PMID: 20438207 DOI: 10.1037/a0018269] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
OBJECTIVE Impairment in odor-naming ability and in verbal and visual semantic networks raised the hypothesis of a breakdown in the semantic network for odors in Alzheimer's disease (AD). The current study addressed this hypothesis. METHOD Twenty-four individuals, half patients with probable AD and half control participants, performed triadic-similarity judgments for odors and colors, separately, which, utilizing the multidimensional scaling (MDS) technique of individual difference scaling analysis (INDSCAL), generated two-dimensional configurations of similarity. The abilities to match odors and colors with written name labels were assessed to investigate disease-related differences in ability to identify and conceptualize the stimuli. In addition, responses on attribute-sorting tasks, requiring the odor and color perceptions to be categorized as one polarity of a certain dimension, were obtained to allow for objective interpretation of the MDS spatial maps. RESULTS Whereas comparison subjects generated spatial maps based predominantly on relatively abstract characteristics, patients with AD classified odors on perceptual characteristics. The maps for patients with AD also showed disorganized groupings and loose associations between odors. Their normal configurations for colors imply that the patients were able to comprehend the task per se. The data for label matching and for attribute sorting provide further evidence for a disturbance in semantic odor memory in AD. The patients performed poorer than controls on both these odor tasks, implying that the ability to identify and/or conceptualize odors is impaired in AD. CONCLUSION The results provide clear evidence for deterioration of the structure of semantic knowledge for odors in AD.
Collapse
Affiliation(s)
- Jill Razani
- San Diego State University-University of California San Diego Joint Doctoral Program in Clinical Psychology, CA, USA
| | | | | | | |
Collapse
|
29
|
Bobes MA, García YF, Lopera F, Quiroz YT, Galán L, Vega M, Trujillo N, Valdes-Sosa M, Valdes-Sosa P. ERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280A PS-1 mutation. Hum Brain Mapp 2010; 31:247-65. [PMID: 19650138 DOI: 10.1002/hbm.20861] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
Although subtle anatomical anomalies long precede the onset of clinical symptoms in Alzheimer's disease, their impact on the reorganization of brain networks underlying cognitive functions has not been fully explored. A unique window into this reorganization is provided by presymptomatic cases of familial Alzheimer's disease (FAD). Here we studied neural circuitry related to semantic processing in presymptomatic FAD cases by estimating the intracranial sources of the N400 event-related potential (ERP). ERPs were obtained during a semantic-matching task from 24 presymptomatic carriers and 25 symptomatic carriers of the E280A presenilin-1 (PS-1) mutation, as well as 27 noncarriers (from the same families). As expected, the symptomatic-carrier group performed worse in the matching task and had lower N400 amplitudes than both asymptomatic groups, which did not differ from each other on these variables. However, N400 topography differed in mutation carrier groups with respect to the noncarriers. Intracranial source analysis evinced that the presymptomatic-carriers presented a decrease of N400 generator strength in right inferior-temporal and medial cingulate areas and increased generator strength in the left hippocampus and parahippocampus compared to the controls. This represents alterations in neural function without translation into behavioral impairments. Compared to controls, the symptomatic-carriers presented a similar anatomical shift in the distribution of N400 generators to that found in presymptomatic-carriers, albeit with a larger reduction in generator strength. The redistribution of N400 generators in presymptomatic-carriers indicates that early focal degeneration associated with the mutation induces neural reorganization, possibly contributing to a functional compensation that enables normal performance in the semantic task.
Collapse
Affiliation(s)
- María A Bobes
- Cognitive Neuroscience Department, Cuban Center for Neuroscience, Havana, Cuba.
| | | | | | | | | | | | | | | | | |
Collapse
|